INTRODUCTION {#S1}
============

Metazoan development begins with a single totipotent cell that gives rise to numerous cell types, each expressing lineage-restricted sets of genes. The activation of gene transcription in the embryo relies on maternal transcription factors (TFs), which sit high in the regulatory hierarchy to coordinate the gene regulatory cascades that lead to the stereotypical development of embryos. Zygotic gene activation (ZGA) is a major regulatory event in which control of the zygotic genome is transferred from maternal to zygotic TFs ([@R43]). While the timing of the transition differs between species, all undergo ZGA, which is controlled by maternal inputs. With the exception of amniotes, the processes of germ layer specification are coupled to ZGA and depend on unequally distributed maternal determinants present in the egg before fertilization ([@R65]). These maternal inputs are the first to specify the differentiation of germ layer cell types.

Maternal TFs presumably coordinate the actions of enhancers, which are *cis*-regulatory modules (CRMs) that dock numerous TFs, to regulate the activity of gene promoters. Since TFs drive lineage-specific transcription programs by binding CRMs dispersed throughout the genome, a major question that remains to be addressed is how maternal TFs bind specific regions in the chromatin to endow the transcriptional responses that initiate germ layer specification, patterning, and subsequent differentiation. We address this fundamentally important biological question by going back to the earliest stages of embryonic development, when transcription from the embryonic genome has not yet begun, the number of different cell types is small, and the genome appears relatively naive.

Genomic studies of human and mouse embryonic stem cells have suggested a role for the epigenetic priming of CRMs and promoter regions ([@R11]; [@R50]). Priming of these sites is thought to play important roles in the deployment of gene regulatory networks (GRNs). However, examination of the chromatin states of early *Xenopus*, zebrafish, and *Drosophila* embryos have not been able to find epigenetic signatures that are frequently associated with active or repressive enhancer states. In *Xenopus*, chromatin immunoprecipitation (ChIP)-qPCR reveals that histone H3R8me2 activating marks appear on *sia1* and *nodal3*, expressed before the major wave of ZGA ([@R9]), but the majority of enhancer chromatin marks appear to arise during the major ZGA phase ([@R2]; [@R28]; [@R37]). Therefore, before ZGA, cleavage, and early blastula stage, chromatin is free of both the activating enhancer marks H3K4me1 and H3K27ac and permissive H3K4me3, as well as repressive H3K27me3 histone marks. Similarly, in zebrafish, neither H3K4me3 nor H3K27me3 were detected before ZGA; and a study of a larger cohort of histone modifications in *Drosophila,* which includes H3K4me1, H3K4me3, and H3K27me3, showed that epigenetic states are largely established post-ZGA ([@R94]; [@R59]). Furthermore, we previously demonstrated that the maternally expressed forkhead-domain TF Foxh1 binds to the genome during cleavage stages pre-ZGA, before the appearance of activating enhancer marks, suggesting that Foxh1 selectively pre-marks CRMs on mesendodermal genes ([@R14]). These findings raise an important question about how active CRMs are chosen and activated during germ layer specification by maternal TFs.

In *Xenopus*, a subset of maternal RNAs are specifically enriched animally (future ectoderm) or vegetally (future endoderm) in the egg, and these factors are subsequently asymmetrically inherited by different blastomeres. Specification of the endodermal germ layer is regulated by the maternal T-box TF Vegt ([@R89]; [@R61]; [@R105]; [@R38]; [@R106]; [@R18]; [@R100]), which sits at the top of the hierarchy of both endodermal and mesodermal gene regulatory cascades ([@R15]). These experiments show that Vegt is capable of activating both mesodermal and endodermal genes, implying that other TFs are involved in restricting the function of Vegt to endoderm gene activation in the vegetal pole cells fated to this lineage. This raises important questions. What are the other maternal TFs involved in endoderm specification? How do these TFs interact to activate selective enhancers to coordinate the endodermal gene regulatory program? Here, we report that Otx1 and Vegt act together with Foxh1 to co-bind endoderm CRMs harboring binding motifs for these 3 TFs before the onset of ZGA and to initiate the recruitment of RNA polymerase II (Pol II) to begin endodermal differentiation programs. CRMs pre-marked by Otx1, Vegt, and Foxh1 binding (OVF-CRMs) subsequently serve as docking sites for numerous other zygotically active TFs, including Foxa, Smad2/3, and Gsc. Furthermore, OVF-CRMs tend to cluster near endodermal genes, forming super-enhancers (SEs), which are activated during ZGA. Our findings are consistent with the view that early line-age specification is driven by the coordinated binding of critical maternal TFs to selective OVF-CRMs or CRM clusters that regulate lineage-specific gene expression. This results in the recruitment of epigenetic regulators that modify the chromatin template to further facilitate the assembly of transcriptional machinery as development proceeds.

RESULTS {#S2}
=======

RNA-Seq Screen for Maternal Regulators of Endodermal Fate {#S3}
---------------------------------------------------------

We wished to identify maternal TFs that may play roles in endodermal specification in the early embryo. Therefore, we examined maternal transcript localization in cleavage stage *Xenopus tropicalis* embryos before the onset of ZGA ([Figure 1A](#F1){ref-type="fig"}). Eight-cell embryos were chosen, as this is the earliest stage at which animal and vegetal hemispheres are segregated into blastomeres by an equatorial cleavage plane and ZGA has not occurred. RT-qPCR and RNA sequencing (RNA-seq) analysis on these samples showed the expected vegetal localization of *vegt* and *gdf1*/*vg1* RNAs, as well as the animal localization of *foxi2* RNA ([Figures S1A](#SD1){ref-type="supplementary-material"}--[S1D](#SD1){ref-type="supplementary-material"}). We identified 309 genes that are differentially expressed between the animal and vegetal cells ([Figure S1E](#SD1){ref-type="supplementary-material"}; [Table S1](#SD2){ref-type="supplementary-material"}). Functionally, these genes are consistent with the biological processes occurring during early embryogenesis as suggested by Gene Ontology (GO) analysis, revealing terms such as "developmental process" and "multicellular organism development" (germ layer formation); "lipid biosynthetic process" (yolk localization in putative endodermal cells); "cytoskeleton organization" and "microtubule-based process" (animal-vegetal RNA microtubule-based translocation); and "developmental process involved in reproduction" (germ plasm localization in the vegetal pole) ([Figure S1F](#SD1){ref-type="supplementary-material"}). While hundreds of TFs are expressed in the egg ([@R8]), only a small fraction are expressed in a regionalized manner: 9 TFs are enriched vegetally, while 4 TFs are enriched animally ([Figure 1B](#F1){ref-type="fig"}). The *vegt* and *otx1* genes are among the most highly expressed vegetally and are the most differentially expressed (\>8-fold) between vegetal and animal blastomeres ([Figure 1C](#F1){ref-type="fig"}). Our findings are consistent with previous RNA-seq-based screens for localized factors, which showed the vegetal enrichment of *otx1* ([@R20]; [@R72]). Previously, *otx1* transcripts were detected in the vegetal pole of oocytes ([@R73]); however, their expression pattern in early embryos has not been well described. Consistent with our RNA-seq, whole-mount *in situ* hybridization shows that *otx1* is expressed in the vegetal mass (presumptive endoderm) and is excluded from the embryonic marginal region (presumptive mesoderm) ([Figures 1D](#F1){ref-type="fig"}--[1F](#F1){ref-type="fig"}). While Otx1 has not yet been implicated in vertebrate germ layer formation, echinoderm ([@R36]; [@R74]) and ascidian ([@R95]) Otx TFs control endodermal specification and are similarly expressed in a variety of deuterostomes ([Figure S2](#SD1){ref-type="supplementary-material"}). We therefore hypothesized that Otx1 is an important regulator of endoderm formation in *Xenopus*, perhaps functioning together with maternal Vegt.

Vegt and Otx1 Combinatorially Specify the Endodermal Transcriptome {#S4}
------------------------------------------------------------------

To gain insight into the role of Otx1 in the endoderm, we expressed Otx1 in animal cap cells (presumptive ectoderm) and assayed for the induction of endodermal genes by RT-qPCR at early gastrula stage 10.5 ([Figure 2A](#F2){ref-type="fig"}). Otx1 is sufficient to activate endodermal markers such as *nodal*, *mixer*, and *darmin*, in addition to *foxa2,* which is expressed in both endodermal and mesodermal layers.

Next, we tested whether Otx1 and Vegt collaborate, positively and/or negatively, to regulate endodermal gene expression. We microinjected a single dose of *vegt* or *otx1* mRNA or a cocktail of these 2 mRNAs into the animal pole at the 1-cell stage and assayed for endodermal and mesodermal gene expression in dissected animal caps. As expected, Otx1 and Vegt alone act as activators of the endodermal genes *nodal* and *mixer* ([Figure 2B](#F2){ref-type="fig"}). Combinatorially, Otx1 and Vegt additively activate the expression of *mixer*. We find a strong synergistic induction of *nodal* in the presence of both mRNAs. Conversely, Otx1 strongly downregulates the induction of the mesodermally expressed gene *fgf20* caused by Vegt ([@R53]). We then performed dose-response experiments, in which a subthreshold concentration of *vegt* mRNA was kept constant and increasing doses of *otx1* were added ([Figure 2C](#F2){ref-type="fig"}). Increasing doses of Otx1 induced *nodal* and *mixer* expression, with *nodal* being more sensitive to Otx1 dose than *mixer*. *fgf20* was strongly repressed even at the lowest Otx1 dose. This finding also proposes a dual function for maternal Otx1-promoting endoderm development vegetally, while repressing mesodermal development in the endoderm by blocking the expression of *fgf20*.

We examined the genome-wide interaction between Otx1 and Vegt in regulating mesendodermal genes by using the same *vegt* and *otx1* mRNA titration conditions followed by RNA-seq analysis. To identify similarly regulated genes, we searched our RNA-seq expression profiles for the dose-response patterns of *nodal, mixer*, and *fgf20*. We identified the 50 most highly correlated genes with similar regulation to the patterns of *nodal, mixer*, and *fgf20* by ranking Pearson correlation coefficients ([Table S2](#SD1){ref-type="supplementary-material"}). Among the genes that are regulated similarly to the *nodal* and *mixer* types are *tbx3, lefty, lhx1, snai1, cer*, and *mix1*, which show enriched expression in the endoderm of the early gastrula. Among the *fgf20*-type regulated genes are the mesodermally expressed genes *fgf4* and *wnt11b*. The gastrula stage expression pattern of *nodal* and *mixer* type genes are consistently strongest in the endoderm, while the *fgf20*-type genes are most strongly expressed in the mesoderm ([Figure 2D](#F2){ref-type="fig"}).

To assess the combinatorial roles of endogenous Otx1 and Vegt, we blocked their activities by injecting translation-blocking antisense morpholino oligonucleotides (MOs) against *vegt* ([@R81]) and *otx1* ([Figures S3A](#SD1){ref-type="supplementary-material"} and [S3B](#SD1){ref-type="supplementary-material"}) into embryos, either independently or in combination. Vegetal masses were dissected at gastrula stage 10.5, followed by RNA-seq. Single knockdowns (KDs) of Vegt or Otx1 affected the expression of 275 and 203 genes, respectively, based on a 2-fold cutoff criterion ([Figures 2E](#F2){ref-type="fig"} and [2F](#F2){ref-type="fig"}). However, the expression of a much larger cohort of 376 genes is affected in the presence of both MOs. Furthermore, genes in the latter category are influenced by independent KDs of *vegt* or *otx1*, although the effect is not as strong as in the double MO ([Figures 2G](#F2){ref-type="fig"} and [2H](#F2){ref-type="fig"}). This suggests that a 2-fold cutoff is too stringent to identify some Vegt or Otx1 targets and that a double MO KD is useful for detecting the combinatorially regulated genes. Among the genes that are affected are the mesodermally expressed genes *fgf20* and *mespa*, which are both inhibited by Vegt and Otx1 ([Figure 2I](#F2){ref-type="fig"}). The endodermally expressed genes *foxa1* and *hnf1b* are activated by both Vegt and Otx1 ([Figure 2I](#F2){ref-type="fig"}). Spatially, the Vegt and Otx1 negatively co-regulated genes tend to be expressed ectodermally or mesodermally, whereas positively co-regulated genes tend to be expressed endodermally ([Figure 2J](#F2){ref-type="fig"}). Overall, our experiments support the notion that maternal Vegt and Otx1 function in a combinatorial manner to drive the proper expression of endodermal genes while minimizing the expression of genes for alternative cell fates.

Vegt and Otx1 Co-bind to Endodermal *cis*-Regulatory Modules before the Onset of ZGA {#S5}
------------------------------------------------------------------------------------

We previously showed that the ubiquitously expressed Foxh1 binds to the genome before ZGA and before the appearance of promoter-bound Pol II and H3K4me1 and Ep300 enhancer marks ([@R14]). We therefore asked whether the endoderm-specific TFs Vegt and Otx1 also interact with the genome before the onset of ZGA. Chromatin immunoprecipitation coupled with deep sequencing (ChIP-seq) was used to investigate Vegt and Otx1 binding at early blastula stage 8. The quality of Vegt ([@R91]) and Otx1 antibodies was verified ([Figures S3C](#SD1){ref-type="supplementary-material"} and [S3D](#SD1){ref-type="supplementary-material"}). We identified 5,151 and 21,711 biologically reproducible Otx1- and Vegt-bound regions, respectively. *De novo* motif analysis of the bound sequences identified a variation of the Bicoid-type homeodomain (TAATCCCY) ([@R21]) and T-box half-site motifs (TCACACCT) ([@R19]) for Otx1 and Vegt, respectively ([Figure S4](#SD1){ref-type="supplementary-material"}). Both Vegt and Otx1 bind to mesodermal and endodermal genes such as *nodal6, sox17b, mix1, mixer, fgf20, gsc*, and *hhex*, and their binding regions are highly overlapping ([Figures 3A](#F3){ref-type="fig"} and [3B](#F3){ref-type="fig"}). The set of Vegt and Otx1 overlapping peaks represents 64% of Otx1 peaks and 18% of Vegt peaks. Simulation of a set of peaks of similar size to the Otx1 peak set across the genome shows an average overlap of 56 (1.1%) peaks over 1,000 trials with the 21,711 Vegt peaks, suggesting that the overlap between Vegt and Otx1 chromatin binding is statistically significant (p \< 2.2e-16).

We then examined the distribution of peaks relative to genomic features. Approximately 1.1% of the entire *X. tropicalis* genome represents a promoter-proximal sequence (within 1 kb upstream of transcription start sites \[TSSs\]), \~25% is intronic and \~70% is intergenic ([Figure 3C](#F3){ref-type="fig"}). Vegt and Otx1 binding is enriched 2-to 3-fold in promoter-proximal regions and \~1.3-fold in intronic regions at the expense of intergenic regions. Despite this enrichment, \>90% of Vegt and Otx1 binding resides in the intronic and intergenic regions, suggesting binding to enhancers over promoters. By assigning these binding regions to the nearest genes, we find that Vegt and Otx1 tend to bind to endodermal and mesodermal genes, rather than ectodermal genes ([Figure 3D](#F3){ref-type="fig"}). Furthermore, by identifying genes with an adjacent ChIP binding peak that are affected by independent morpholino KD from the RNA-seq experiments, we were able to identify a set of 74 Vegt and 21 Otx1 direct target genes ([Table S3](#SD3){ref-type="supplementary-material"}). By looking at genes affected by the Vegt/Otx1 double MO and that are bound by both TFs, we identified 47 genes that are combinatorially directly regulated by Vegt and Otx1, including the endodermally expressed genes *gata4*, *foxa1*, and *pnhd*.

Next, we asked whether Vegt and Otx1 can engage chromatin during the cleavage stages by ChIP-qPCR on 32-cell stage embryos, 3--4 cell cycles pre-ZGA ([Figures 3E](#F3){ref-type="fig"} and [3F](#F3){ref-type="fig"}). Strong binding of endogenous Vegt and Otx1 was detected during the pre-ZGA stages on the regulatory regions of mesodermal and endodermal genes. These results, combined with similar observations on Foxh1 ([@R14]), suggest that maternal TFs engage chromatin during the transcriptionally quiescent cleavage stages, before the establishment of enhancer marks.

Maternal Otx1 and Vegt Assemble on *cis*-Regulatory Regions Together with Foxh1 {#S6}
-------------------------------------------------------------------------------

A *de novo* motif analysis of the regions bound by Otx1 and Vegt was used to identify a set of candidate maternal TFs that co-regulate genes with Otx1 and Vegt. This analysis ([Figure S4](#SD1){ref-type="supplementary-material"}) identified their respective motifs and the Fox motif. This finding suggests that Vegt and Otx1 co-bind in the genome together with the ubiquitously expressed TF Foxh1. A comparison of Otx1 and Vegt peaks to Foxh1 peaks at blastula stage 8 shows that \>70% of Otx1 peaks and \>25% of Vegt peaks overlap with Foxh1 peaks ([Figures 4A](#F4){ref-type="fig"} and [4B](#F4){ref-type="fig"}). To ensure co-occupancy in the same endodermal cells, we performed sequential ChIP-qPCR. ChIP was performed using the Otx1 antibody, followed by dissociation, and then a second round of ChIP was performed using Vegt, Foxh1, or FLAG (as a negative control) antibodies. Regions bound by Otx1 are positive for Foxh1 and Vegt binding, but not FLAG ([Figures 4B](#F4){ref-type="fig"} and [4C](#F4){ref-type="fig"}). Co-occupancy possibly favors the binding of TFs on these CRMs over other regions of the genome. To test this model, Foxh1 expression was knocked down using a morpholino ([@R16]) and assessed as to whether Otx1 and Vegt binding requires the presence of Foxh1. In the absence of Foxh1, the association of both Otx1 and Vegt in multiple regions is decreased ([Figure 4D](#F4){ref-type="fig"}). These observations suggest that these 3 maternal TFs co-occupy CRMs in the genome as an assembly.

Pre-marking of Endodermal CRMs by Maternal Otx1, Vegt, and Foxh1 Assembly {#S7}
-------------------------------------------------------------------------

As ChIP-seq identified thousands of possible regulatory regions, we wished to determine which TF bound sites are active. We hypothesized that the Otx1, Vegt, and Foxh1 co-bound CRMs (OVF-CRMs) correspond to functional *cis*-regulatory modules. We looked at whether these sites are potential binding sites for zygotically endodermally active TFs Ctnnb1/β-catenin, Foxa, Gsc, Otx2, and Smad2/3 ([@R16]; [@R102]; [@R68]; [@R14]). OVF-CRMs flanking endodermally expressed genes such as *foxa1, pnhd*, and *admp* show extensive co-binding of zygotic TFs ([Figure 5A](#F5){ref-type="fig"}). Genome-wide analysis supports this finding, as ChIP-seq signals of zygotic TFs overlap with the location of OVF-CRMs ([Figure 5B](#F5){ref-type="fig"}). Consistent with our hypothesis, CRMs bound by either 1- or 2-way combinations of Otx1, Vegt, or Foxh1 showed weaker zygotic TF ChIP read density than OVF-CRMs ([Figures 5B](#F5){ref-type="fig"} and [S5A](#SD1){ref-type="supplementary-material"}). These observations suggest that the maternally established OVF-CRMs are preferential sites for subsequent assembly of zygotically active TF recruitment.

While CRMs that act as enhancers typically display epigenetic marks, in early frog, fish, and *Drosophila* embryos, enhancer marks are not present until post-ZGA ([@R28]; [@R37]; [@R94]; [@R59]). We therefore wished to determine whether OVF-CRMs are subsequently decorated with the enhancer marks H3K4me1, H3K27ac, and Ep300 ([@R28]; [@R37]). As a negative control, when H3K4me3 was plotted in regions centered around maternal TFs, we were unable to detect enrichment of this promoter mark ([Figure 5C](#F5){ref-type="fig"}). In contrast, the general enhancer mark H3K4me1 correlates well with the OVF-CRMs ([Figure 5D](#F5){ref-type="fig"}). This finding is consistent with the earlier finding that Otx1 and Vegt tend to bind in intergenic and intronic regions of the genome. The general enhancer mark H3K4me1 is absent at stage 8, while Otx1, Vegt, and Foxh1 binding occurs well before this stage ([Figure 3](#F3){ref-type="fig"}). Our results show that the H3K4me1 mark is largely established in OVF-CRMs by stage 9 and that this mark appears to persist through later embryonic developmental stages ([Figure 5D](#F5){ref-type="fig"}). Ep300 peaks are not detectable before stage 8 ([@R37]) and become detectable after blastula stage 9, after ZGA has begun. Post-ZGA Ep300 displays a strong signal at the regions of maternal TF co-binding ([Figure 5E](#F5){ref-type="fig"}). The H3K27ac active enhancer mark is weakly detectable at stages 8 and 9; however, the bimodal distribution pattern of this mark around the OVF-CRMs becomes more pronounced at stage 10 ([Figure 5F](#F5){ref-type="fig"}). These marks are particularly enriched in the OVF-CRMs when compared to other regions having either only 1 or 2 of Otx1, Vegt, or Foxh1 binding ([Figures 5D](#F5){ref-type="fig"}--[5F](#F5){ref-type="fig"} and [S5B](#SD1){ref-type="supplementary-material"}). These datasets, taken together with the detection of Otx1, Vegt, and Foxh1 binding as early as the 32-cell stage ([Figures 3E](#F3){ref-type="fig"} and [3F](#F3){ref-type="fig"}), suggest that maternal TF assembly pre-marks OVF-CRMs and that OVF-bound CRMs function at later developmental stages as enhancer elements that recruit other zygotically expressed TFs.

Otx1, Vegt, and Foxh1 Regulate Pol II Recruitment to OVF-CRMs {#S8}
-------------------------------------------------------------

To further demonstrate the enhancer regulatory function of OVF-CRMs, we examined the recruitment and activity of Pol II on these elements. Active enhancers are known to interact, via DNA looping, with promoters of their target genes and to recruit Pol II to their promoters. Therefore, Pol II should be detectable on active enhancer regions. We therefore hypothesized that Otx1, Vegt, and Foxh1 regulate Pol II recruitment to OVF-CRMs near endodermal genes that are regulated by these TFs. Ectopic expression of Otx1 and Vegt in animal caps (Foxh1 is ubiquitously expressed) increased Pol II association with OVF-CRMs ([Figure 5G](#F5){ref-type="fig"}). Conversely, simultaneous morpholino KD of Otx1, Vegt, and Foxh1 drastically reduces Pol II association to these regions in vegetal tissue ([Figure 5H](#F5){ref-type="fig"}), indicating that the OVF TFs form an active complex with Pol II.

Enhancer RNAs (eRNAs) represent a class of relatively short non-coding RNA molecules transcribed from the DNA sequence of enhancer regions. The expression of eRNAs is frequently correlated with the chromatin marks of active enhancers ([@R49]; [@R51]). We therefore tested whether OVF-CRMs produce non-coding eRNAs, By ectopic expression of Otx1 and Vegt in animal caps, we detected increased levels of eRNA transcription from OVF-CRMs in comparison to uninjected control animal caps ([Figure 5I](#F5){ref-type="fig"}), suggesting that OVF-CRMs respond to Otx1 and Vegt inputs. Overall, based on zygotic TF binding, epigenetics changes, Pol II recruitment, and eRNA expression, we conclude that OVF-CRMs are active CRMs regulated by Otx1, Vegt, and Foxh1.

Endodermal Super Enhancers Are Epigenetically Distinct from Regular Enhancers and Are Hubs of TF Binding Sites {#S9}
--------------------------------------------------------------------------------------------------------------

During our analysis of endodermally enriched maternal TF binding, we noticed that not only do these maternal TFs co-bind but also their CRMs tend to form clusters near endodermally expressed genes. This CRM clustering is reminiscent of super-enhancers (SEs), a cluster of enhancers with unusually high epigenetic marking established near key cell identity genes ([@R60]; [@R98]). From a gene regulatory standpoint, this class of enhancers is particularly appealing as (1) they are much more likely than regular enhancers (REs) to regulate their closest neighboring gene and (2) they are stronger activators of gene expression than REs ([@R98]). Due to these special properties of SEs, we wished to explore whether OVF TFs associate with endodermal SEs established during germ layer formation. To identify SEs, we performed H3K4me1 ChIP-seq at the gastrula stage on endodermal cells from dissected vegetal masses. After read mapping and peak calling, we obtained 18,380 peaks. We excluded peaks in the promoter regions, and the remaining 15,836 peaks were used for SE analysis. We used previously described protocols to distinguish between REs and SEs ([@R60]; [@R98]).

From this analysis, we identified 441 SEs ([Table S4](#SD4){ref-type="supplementary-material"}) and 7,468 REs ([Figure 6A](#F6){ref-type="fig"}). As expected, SEs are much longer ([Figure 6B](#F6){ref-type="fig"}) and contain more constituent enhancers than REs ([Figure 6C](#F6){ref-type="fig"}). The embryonic endodermal SEs were identified near genes among which code for regulators of endodermal cell fate genes such as *admp*, *pnhd*, *foxa4*, *sox17*, *hhex*, *frzb*, *gata6*, and *foxa2* ([Figures 6D](#F6){ref-type="fig"} and [S6A](#SD1){ref-type="supplementary-material"}).

Epigenetically, SEs are distinct from REs as they contain a much stronger signal of the H3K4me1 mark. To compare the epigenetics between SEs and REs, we used published bulk embryo datasets: H3K4me1, Ep300, and H3K27ac as markers of enhancers; H3K27me3, Jarid, and Ezh2 as polycomb markers; and H3K9me2 and H4K20me3 as markers of hetero-chromatin. Our data support the idea that these SEs are important regulators of cell fate specification as they are enriched with enhancer marks across early development ([Figures 6E](#F6){ref-type="fig"} and [S6B](#SD1){ref-type="supplementary-material"}). In addition, they are enriched for polycomb marks, which suggest that SEs, while acting as *cis*-activators of gene expression, could be used for repression in alternative cell fates. On the contrary, heterochromatin marks ChIP read densities are similar between REs and SEs.

As we previously identified Otx1, Vegt, and Foxh1 as regulators of endodermal fate, we asked whether these maternal TFs are important in the establishment of the endodermal SEs. By comparing the ChIP read density, we find that all 3 maternal TFs are enriched in SEs ([Figure 6F](#F6){ref-type="fig"}). In particular, Foxh1 appears to have the strongest enrichment, suggesting a key role for Foxh1 in establishing SEs in the endoderm. We then asked whether combinations of TF binding are critical in establishing SEs. We compared the SE and RE occupancy of OVF-CRMs, 2-TF bound CRMs (2-way combinations of Otx1, Vegt, and Foxh1), and 1-TF bound CRMs. OVF-CRMs are much more likely to overlap with H3K4me1 peaks and are enriched in both REs and SEs ([Figure 6G](#F6){ref-type="fig"}). In addition to maternal TF binding, SEs are also enriched for endodermally active zygotic factors ([Figure S6C](#SD1){ref-type="supplementary-material"}). These analyses suggest that endodermal SEs are epigenetically distinct from REs and are hubs for endodermal maternal and zygotic TF binding.

SEs Are Associated with Endodermally Expressed Genes Activated during ZGA {#S10}
-------------------------------------------------------------------------

While SEs are located near known endodermal genes ([Figures 6D](#F6){ref-type="fig"} and [S6A](#SD1){ref-type="supplementary-material"}), we wanted to obtain a whole-genome view of genes regulated by endodermal SEs ([Table S4](#SD4){ref-type="supplementary-material"}). By performing GO analysis on the set of 490 genes associated with SEs, we obtained terms related to embryonic development and TF activity, suggesting that these genes are regulators of cell fate ([Figure 6H](#F6){ref-type="fig"}). In general, these genes are activated during ZGA (between 4 and 5 hours post-fertilization), unlike genes associated with REs or randomly selected genes that are not associated with REs or SEs ([Figure 6I](#F6){ref-type="fig"}). Genes associated with SEs tend to be more highly expressed spatially than RE-associated genes or random genes, regardless of germ layer tissue expression. While RE-associated genes tend to be similarly expressed across the 3 germ layers, the SE-associated genes are enriched in the endoderm relative to the ectoderm ([Figure 6J](#F6){ref-type="fig"}). SE-associated gene expression is also enriched in the mesoderm over the ectoderm, which is consistent with the appearance of genes expressed in both the mesoderm and endoderm such as *foxa2* and *foxa4*. Overall, our analyses suggest that SEs are established near genes coding for the key regulators of endodermal fate activated during ZGA.

Otx1, Vegt, and Foxh1 Regulate the Expression of SE-Associated Genes {#S11}
--------------------------------------------------------------------

While SEs are likely regulated by numerous TFs ([@R60]; [@R98]), we wondered whether the maternal TFs Otx1, Vegt, and Foxh1 are required for the regulation of genes associated with endodermal SEs. Genes that are associated with SEs are downregulated by the combinatorial KD of Otx1 and Vegt ([Figure 6K](#F6){ref-type="fig"}). Similarly, Foxh1 KD ([@R16]) also decreased the expression of SE-associated genes. On the contrary, genes associated with REs do not show a statistically significant downregulation in any of the KD experiments. Our analysis suggests that Otx1, Vegt, and Foxh1 are highly active in SE regions and are important regulators of the genes associated with these regions.

DISCUSSION {#S12}
==========

Here, we identify a role for maternal Otx1 in vertebrate endodermal specification and explore its relation with 2 other maternal TFs, Vegt and Foxh1. Based on our findings, we propose the following model. The genome in early embryonic cells is compact, relatively inaccessible, and largely lacking in the chromatin marks associated with enhancer activation (or repression) until ZGA. Otx1, Vegt, and Foxh1 together gain entry to the chromatin and bind to CRMs at least as early as the 32-cell stage. Since these TFs can bind to DNA target sites, presumably in relatively closed chromatin ([@R3]; [@R4]), before the activation of enhancers and gene expression modulation, these maternal TFs act as pioneer TFs that initiate the establishment of functional *cis*-regulatory regions in the embryo ([@R104]). Following the initial gene activation, these CRMs would remain functional platforms for TF recruitment, as they are later occupied by zygotically expressed TFs produced shortly after ZGA. Enhancer marks appear around the onset of ZGA and strengthen thereafter, suggesting that these marks are deposited in response to gene activation or repression rather than regulating maternal TF association to the genome. The highest signal for these enhancer marks occurs on CRMs that are clustered, forming SEs around developmentally relevant genes, and these SEs are enriched in Otx1, Vegt, and Foxh1 binding. The roles of maternal TFs in regulating zygotic gene expression are likely to be many. At least one role is the enhanced recruitment of Pol II (leading to eRNA expression). It is tempting to speculate that maternal TFs also recruit histone-modifying factors to establish the earliest zygotic chromatin states at and after the onset of ZGA.

Interplay of Maternal TFs and Chromatin States {#S13}
----------------------------------------------

The sequence of events leading to the appearance of open chromatin, epigenetic marks, and TF binding is under intensive investigation. The early metazoan embryonic (pre-ZGA) genome lacks enhancer marks, and both permissive and repressive histone modifications (H3K4me3 and H3K27me3, respectively) are established during late blastula and gastrula stages ([@R2]; [@R28]; [@R37]; [@R94]; [@R59]). We find that combinatorial binding of the maternal TFs Otx1, Foxh1, and Vegt occurs pre-ZGA and before the appearance of H3K4me1, Ep300, and Pol II recruitment. This suggests that chromatin binding by maternal TFs is not controlled by epigenetics, but rather by TF binding preferences for DNA motifs influenced by protein-protein interactions on CRMs.

The maternal TFs may also be involved in the recruitment of the writers of epigenetic marks. An example of epigenetic writer recruitment by TFs during *Xenopus* dorsal-ventral patterning is the facilitation by Ctnnb1/β-catenin of Prmt2 (protein arginine methyltransferase 2) binding to the *sia1* regulatory region ([@R9]). Prmt2 then deposits H3R8me2 marks, resulting in the transcriptional activation of *sia1*. Inhibition of zygotic transcription through α-amanitin treatment showed that maternal factors are involved in the majority of H3K4me3 promoter marks and H3K27me3 polycomb repressive marks and a subset of Ep300 recruitment through late gastrula stages ([@R37]). While it is unclear how these maternal TFs interact with chromatin modifiers, we believe that they are the major drivers of site-selective chromatin modifications in the early embryo. Thus, a better understanding of the interplay between the maternal TFs and chromatin modifiers will be essential to comprehend the molecular mechanism of ZGA.

While our evidence suggests that the pioneering activity of maternal TFs is critical for establishing epigenetic states and Pol II function, it is possible that the same maternal TFs are important for establishing open chromatin ([@R104]). Early *Xenopus* embryos contain high levels of nucleosomes, which results in relatively close chromatin, and these nucleosomes are therefore viewed as repressors of gene expression pre-ZGA ([@R3]; [@R4]). The basal TF Tbp, which recruits Pol II to gene promoters, competes with the nucleosomes to initiate gene transcription ([@R77]). Maternal TFs possibly perform a similar function in enhancer regions where clusters of DNA binding motifs are located. This mechanism has been observed during ZGA in the case of maternally expressed Zelda in *Drosophila* ([@R22]; [@R88]) and Pou5f3 in zebrafish ([@R42]), whereby these TFs are required for chromatin opening in their respective binding sites. This is a testable mechanism using techniques such as assay for transposase-accessible chromatin sequencing (ATAC-seq) and DNase-seq, and whether *Xenopus* maternal TFs open chromatin is a critical question that must be addressed to understand the full repertoire of maternal TF function.

Enhancers and SEs in Development {#S14}
--------------------------------

SEs have been understudied in the context of early embryogenesis. Via interrogation of genome-wide binding, we find numerous regions co-occupied by the maternal TFs Otx1, Vegt, and Foxh1, suggesting that these factors collaborate to regulate gene behavior. While maternal TFs bind to tens of thousands to hundreds of thousands of sites in the genome, we find that the co-bound regions are functional regulatory regions by epigenetic marking and Pol II activity. Regions where these TFs co-bind (OVF-CRMs) are subsequently decorated with epigenetic enhancer marks and become docking sites for numerous zygotically active TFs. We find that a set of SEs that are marked with an unusually high signal of active chromatin marks and zygotic TF binding are clustering around OVF-CRMs and are associated with endodermal specification genes activated during ZGA. It is tempting to speculate that the TFs Otx1, Vegt, and Foxh1 establish a paradigm for the assembly of SEs by maternal TFs, suggesting that maternally controlled SEs regulate key zygotic germ layer-specifying genes during early embryonic development. While we have so far identified an assembly of three maternal TFs on enhancers and SEs, other maternal TFs are likely to be involved in this process. Some candidate maternally expressed TFs include vegetally localized Sox7 ([Figure 1](#F1){ref-type="fig"}; [@R72]; [@R20]) and ubiquitously expressed TFs such as Zic2, Sox3, and Pou5f3/Oct60, motifs of which are enriched under Vegt and Otx1 peaks ([Figure S5](#SD1){ref-type="supplementary-material"}). Although the precise roles of SEs are not well established, the constituent enhancers within these enhancer clusters could function through the combinations of gene expression amplitude modulation and the specification of correct spatial and temporal localization in early embryonic tissues. Sea urchin *endo16* ([@R103]) and *Drosophila eve* ([@R26]; [@R30]) are two well-studied early developmental genes that provide examples for complex regulation by clusters of enhancers, and thus may have similar SE features.

Otx1 in the Context of Endodermal Evo-Devo {#S15}
------------------------------------------

How does the role of Otx1 in early frog embryos apply to the endoderm in other organisms? Otx genes are most well known for their roles in embryonic anterior specification, a function that pre-dates the evolutionary split between deuterostomes and protostomes. The only functional studies on *otx* genes in the initial specification steps of endoderm come from echinoderms, where vegetally localized *otx* activates the expression of multiple endodermal genes ([@R36]; [@R74]), and ascidians, where otx represses mesodermal derivatives ([@R95]). Therefore, we mined publically available *in situ* hybridization and transcriptomic datasets to determine whether *otx1* orthologs are expressed maternally and vegetally. Otx1 orthologs seem to play a role in endoderm formation across deuterostomes, with the exception of amniote embryos. Our analysis shows that Otx1 directly activates *gata4* and *foxa1* in *Xenopus* ([Table S3](#SD3){ref-type="supplementary-material"}), similar to the activation of *gatae* and *foxa* orthologs by Otx in the sea urchin ([@R74]), suggesting the conservation of gene regulatory networks. While much is known about the expression pattern of Otx1 homologs, further functional analysis is needed to uncover their roles in diverse endodermal gene regulatory programs.

Dual Function of Lineage-Specific TFs {#S16}
-------------------------------------

By combining ChIP-seq peaks with the findings from the KD experiments, we identified a set of Vegt-regulated, Otx1-regulated, and co-regulated genes during zygotic gene activation ([Table S3](#SD3){ref-type="supplementary-material"}), further expanding our understanding of the endodermal gene regulatory program ([@R15]). From our list, both Vegt and Otx1 appear to act as direct activators of endodermal gene expression and repressors of mesodermal gene expression.

The function of maternal Vegt has been extensively characterized as an activator of endodermal and mesodermal genes ([@R89]; [@R61]; [@R106]; [@R18]; [@R100]). However, when we analyzed RNA expression in the vegetal mass of Vegt morphants, mesodermal genes were induced, corroborating the previous finding that the putative mesoderm shifts to the vegetal mass in Vegt KDs ([@R106]). Combined with the chromatin binding, our data support a model whereby maternal Vegt acts as a direct repressor of mesodermal genes vegetally. This finding poses a novel inhibitory role for Vegt and suggests that Vegt acts as a dual function TF. This would add Vegt to the list of T-box TFs, which can act as repressors. The list includes mouse Tbx20 ([@R84]), *Xenopus* Tbx3 ([@R32]), zebrafish Tbx24 ([@R47]), *Caenorhabditis elegans* Tbx2 ([@R64]), and *Drosophila* Midline ([@R23]). Mechanistically, the repressive roles of Tbx20, Tbx24, and Midline have been attributed to the interaction with the general co-repressor Tle/Groucho ([@R47]; [@R23]; [@R44]). Alternatively, the switch from the activator to the repressive role of Tbx2 has been attributed to the small ubiquitin-like modifier (SUMO)ylation of this protein ([@R64]). These mechanisms from other T-box family members present some attractive hypotheses in studying the possible mechanism for the repressive function of Vegt.

The role of maternal Otx1 in germ layer specification has not previously been investigated. We identified *otx1* mRNA as vegetally localized, which is consistent with previous studies on *Xenopus* oocytes and early embryos ([@R20]; [@R72]; [@R73]), and sought to understand its role in endoderm specification. Otx1 collaborates with Vegt to activate endodermal gene expression and to repress mesoderm formation. Repression of mesodermal gene expression appears to occur at least in part through Otx1 downregulation of mesodermal Fgf signaling, which inhibits endodermal formation in both *Xenopus* and zebrafish ([@R12], [@R13]; [@R76]). The mechanism for toggling the dual functions of Otx1 on different genes remains unclear, but 2 mechanisms have been proposed. In the first, activation versus repression depends on pairing with other co-bound TFs: Otx2 together with Lhx1 function as an activator, while Otx2 together with Gsc functions as a repressor ([@R102]). A second mechanism suggests that the phosphorylation of Otx2 plays a role in its repressor function ([@R86]) to modulate binding Tle/Groucho ([@R78]). Since these phosphorylation sites are also conserved in Otx1, it is possible that the dual role of Otx1 may be similarly regulated.

In addition to Otx1 and Vegt, Foxh1 has been shown to be a dual function TF ([@R16]; [@R82]). In this study, we have focused on the relation between these maternal TFs and activating enhancer marks. However, it is presently unclear how these TFs inhibitory functions lead to the establishment of repressive chromatin marks. Future work examining the relation between these maternal TFs and chromatin modifying enzymes involved in both activation and repression is needed.

STAR★METHODS {#S17}
============

CONTACT FOR REAGENT AND RESOURCE SHARING {#S19}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Ken W.Y. Cho (<kwcho@uci.edu>)

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S20}
--------------------------------------

*Xenopus tropicalis* males and females were obtained from NASCO (University of Virginia stock) or raised in the laboratory; and were maintained in accordance with the University of California, Irvine Institutional Animal Care Use Committee (IACUC). *X. tropicalis* females were injected with 10 units of Chorulon HCG (Merck and Co.) 1--3 nights before embryo collection and 100 units of HCG on the day of embryo collection. Eggs were collected in a dish coated with 0.1% BSA in 1/9x MMR. The eggs were *in vitro* fertilized with sperm suspension in 0.1% BSA in 1/9x MMR ([@R70]). The embryos were dejellied with 3% cysteine in 1/9x MMR, pH 7.8, 10 minutes after fertilization and were then ready for manipulation. Embryos were staged using the Nieukwoop-Faber developmental table ([@R69]; [@R48]; [@R71]). Microinjections and microdissection of *Xenopus* embryos are described below specific for each experiment.

METHOD DETAILS {#S21}
--------------

### RNA ectopic expression (animal caps) {#S22}

The *Xenopus tropicalis vegt* and *otx1* open reading frames were cloned into the BamHI site of the pCS2+ vector using Gibson cloning ([@R25]). Similarly, the Otx1 open reading frame was cloned into the BamHI site of pCS2+3xFLAG vector to generate an epitope-tagged Otx1. The plasmids were then digested with HpaI and mRNA was generated using by *in vitro* transcription using mMessage mMachine SP6 Transcription Kit (Thermo Fisher Scientific). Ectopic expression was performed by injecting in two opposite sites in the animal cap region at 1--2 cell stage. For experiments that required no embryo fixation, animal caps were dissected an hour prior to harvest. For embryos that were fixed, whole embryos were fixed at the stage of harvest (see ChIP assays and analysis), and animal caps were dissected after fixation.

### Morpholino knockdown and rescue (vegetal masses) {#S23}

*otx1* translation blocking morpholino was designed by GeneTools, Inc., against *X. tropicalis otx1* (5^0^-ATGACATCATGCTCAAGGCTG GACA-3′). The *vegt* (5′-TGTGTTCCTGACAGCAGTTTCTCAT-3′) ([@R81]) and the *foxh1* (Sequence: 5′-TCATCCTGAG GCTCCGCCCTCTCTA-3′) ([@R16]) translation blocking morpholinos were previously tested. *otx1* morpholino rescue was performed using the FLAG-otx1 construct. Morpholino knockdown was performed by injecting directly into the vegetal pole at 1-cell stage. For experiments that required no embryo fixation, vegetal masses were dissected an hour prior to harvest. For embryos that were fixed, whole embryos were fixed at the stage of harvest (see ChIP assays and analysis), and vegetal masses were dissected after fixation.

### Whole mount *in situ* hybridization {#S24}

The protocol of [@R31] with modifications as previously described ([@R7]) was used. Template for *otx1* riboprobes was obtained following PCR amplification from cDNA prepared by Smart-seq2 ([@R75]) reverse transcription. PCR product contained bacteriophage T3 and T7 promoters (underlined below) for the synthesis of sense and antisense probe, respectively. The forward and reverse primers for amplification were: "5′-GCAGC[AATTAACCCTCACTAAAGG]{.ul}TTCAGCGGGGTGGATTGCAG-3′5′-GCAGC[TAATACGACTCACTATAGG]{.ul}acacagggacaaacagagccaa-3′."

### RNA assays {#S25}

**RNA isolation:** RNA was collected from embryo and embryo fragments as previously described ([@R17]). **RT-qPCR Primers:** See [Table S5](#SD5){ref-type="supplementary-material"}. **RT-qPCR:** RNA samples were reverse transcribed using the MMLV reverse transcriptase. qPCR was performed using Roche Lightcycler 480 II using the Roche SYBR green I master mix with the default SYBR green protocol. **RNA-seq:** RNA-seq libraries were generated using Smart-seq2 cDNA synthesis followed by tagmentation ([@R75]), quality-tested using an Agilent Bioanalyzer 2100, quantified using KAPA qPCR and sequenced using Illumina sequencers at the UC Irvine Genomics High Throughput Facility. **Enhancer RNA Primers:** See the ChIP-qPCR section of [Table S5](#SD5){ref-type="supplementary-material"}. **Enhancer RNA detection:** After RNA was isolated, as described above, the resuspended nucleic acids were treated with TURBO DNase at 37°C for 30 minutes to eliminate genomic DNA contamination. RNA was then isolated by phenol/chloroform extraction and isopropanol precipitation. RNA samples were then subjected to reverse transcription, along with a no reverse transcriptase (-RT) control, and qPCR was performed as described above.

### Chromatin immunoprecipitation (ChIP) assays {#S26}

**Antibodies:** The anti-Vegt ([@R91]), anti-Foxh1 ([@R16]), anti-Pol II (Bio-Legend MMS-126R; [@R14]), and anti-H3K4me1 (Abcam; [@R28]; [@R37]) antibodies were previously tested. The rabbit polyclonal anti-Otx1 peptide antibody was generated (GenScript USA Inc.) against the peptide sequence GYTGTGLPFNSSDC (AA 288--301 of the *Xenopus tropicalis* Otx1 protein). **ChIP:** ChIP on *X. tropicalis* embryos was performed as previously described ([@R16]). **ChIP-qPCR Primers:** See [Table S5](#SD5){ref-type="supplementary-material"}. **ChIP-qPCR:** qPCR was performed using Roche Lightcycler 480 II using the Roche SYBR green I master mix with the default SYBR green protocol. **ChIP-seq:** ChIP-seq libraries were generated using Nextflex ChIP-seq kit (Bioo Scientific), analyzed using an Agilent Bioanalyzer 2100, quantified using KAPA qPCR and sequenced using Illumina instruments at the UC Irvine Genomics High Throughput Facility. **Sequential ChIP:** The initial steps of ChIP were performed as previously described. After incubation with the first antibody, elution was performed using 1x TE, pH 8.0, with 10mM DTT, 500 mM NaCl and 0.1% SDS at 37°C for 30 minutes. After the incubation, the eluate was diluted 10x with RIPA. The diluted eluate was incubated with the second antibody and the rest of the ChIP was performed as previously described ([@R24]).

QUANTIFICATION AND STATISTICAL ANALYSIS {#S27}
---------------------------------------

### RNA analysis {#S28}

**RT-qPCR:** Fold change in gene expression was calculated using the ΔΔCp approach and the error among technical replicates was calculated using error propagation and the first approximation of the Taylor expansion. **RNA-seq:** Reads were aligned using RSEM v.1.2.12 ([@R56]) and Bowtie 2 v2.2.7 ([@R52]) to the *Xenopus tropicalis* genome version 9.0 ([@R34]; [@R46]), generating expression values in transcripts per million (TPM) and normalized read counts. **Differential Expression:** Differential expression of genes in normalized read counts between samples was performed using the EBseq v1.8.0 ([@R54]) function *EBTest* on R v3.1.0 ([@R80]). **Pattern matching for similarly regulated genes:** In the combinatorial ectopic expression of Vegt and Otx1 experiment followed by RNA-seq, we first identified genes that were differentially expressed compared to the uninjected control in any of the treatments. From this set of genes, we pattern matched the expression in TPM with the TPM expression of *nodal*, *mixer* and *fgf20* with the *cor* function in R using the Pearson method to identify similarly expressed genes. We then ranked the correlation metric of the entire genome to each of the patterns and selected the 50 most correlated genes ([@R80]). **Gastrula stage gene expression analysis:** Gastrula expression in TPM in five tissue fragments (i.e., animal cap, ventral marginal zone, lateral marginal zone, dorsal marginal zone, and vegetal mass) were obtained from NCBI GEO accession number GSE81458 ([@R8]), and the gastrula stage expression pattern of gene lists were identified using these TPM values. Animal cap expression was used for ectoderm, vegetal mass expression was used for endoderm and the average expression of ventral-, lateral- and dorsal-marginal zones was used for mesoderm. Genes that are maternally-expressed (TPM \> 1 in 0 hpf of the time course RNA-seq ([@R71]), which could mask spatial expression pattern of zygotic genes, are removed from the analysis. For assignment of genes to specific germ layers ([Figure 3D](#F3){ref-type="fig"}), we assigned each gene to the germ layer by which it has the strongest gene expression in TPM. **Time course gene expression analysis:** Gene expression from a ribosomal RNA depleted RNA-seq time-course were obtained from NCBI GEO accession number GSE65785 ([@R71]). The expression in TPM was generated by aligning the reads to the *X. tropicalis* genome as outlined above, and temporal expression of gene lists were identified using these TPM values. **Enhancer RNA detection:** Genomic DNA at 2.5, 25 and 250 pg was assayed using the same qPCR primers to generate a standard curve. The eRNA levels were quantified from the genomic DNA standard curve. The error among technical replicates was calculated using error propagation and the first approximation of the Taylor expansion.

### Chromatin immunoprecipitation analysis {#S29}

**ChIP-qPCR (percent input):** ChIP DNA using 1 embryo equivalent, and ChIP input DNA at 0.1, 0.01 and 0.001 embryo equivalents assayed in triplicates by qPCR. Percent input of ChIP DNA was calculated by generating a linear model of input DNA embryo equivalents and qPCR Cp values. **ChIP-qPCR (fold-change):** When comparing ChIP-qPCR signal between two conditions (knockdown and ectopic expression conditions compared to uninjected wild-type as seen in [Figures 4D](#F4){ref-type="fig"}, [5G](#F5){ref-type="fig"}--[H](#F5){ref-type="fig"}), fold change in ChIP signal was calculated using the ΔΔCp approach and the error among technical replicates was calculated using error propagation and the first approximation of the Taylor expansion. The normalization control region is indicated in each figure in gray with a fold change of 1. **ChIP-seq peak calling and IDR:** Reads were aligned to the *X. tropicalis* genome v9.0 ([@R34]; [@R46]) using Bowtie 2 v2.2.7 ([@R52]) with default options, and peaks were called against stage 8 input DNA ([@R14]) using MACS2 v2.0.10 ([@R107]) with the option -p 0.001 but otherwise default options. ENCODE based irreproducibility discovery rate (IDR) was performed using the following p value thresholds for the following comparisons: 0.01 for original biological replicates, 0.02 for pseudoreplicates of each biological replicate and 0.0025 for pseudoreplicates generated from pooled reads of biological replicates ([@R58]). **Peak location annotation:** Peaks were annotated as 'promoter', 'intron', 'exon', 'intergenic' or 'transcription termination site (TTS)' using HOMER v4.7 using the function *annotatePeaks.pl* ([@R33]). **Motif analysis:** Motif analysis was performed using DREME ([@R6]) and matching identified motifs to databases was performed using TOMTOM ([@R27]). **Genome browser visualization:** Using Samtools v0.1.19, aligned reads in SAM format were converted to BAM format (*samtools view -bS*) and duplicates were removed (*samtools rmdup*) ([@R57]). Bedtools v2.19.1 ([@R79]) was used to convert BAM files to BED format. IGVtools functions *sort* (default options) and *count* (-w 25 -e 250) were used to generate the WIG or TDF files loaded into IGV v2.3.20 ([@R83]). **Accession of published *X. tropicalis* ChIP-seq datasets:** Datasets were downloaded from NCBI GEO using the accession numbers: GSE41161 for Jarid and Ezh2 stage 9 ([@R93]); GSE85273 for Pol II and stage 10 Foxa ([@R14]); GSE67974 for H3K9me2, H4K20me3, H3K4me1, Ep300 and H3K4me3 ([@R37]); GSE56000 for H3K4me1 and H3K27ac ([@R28]); GSE72657 for stage 10 Ctnnb1/β-catenin ([@R68]); and GSE53654 for stage 10 Smad2/3 ([@R16]). The stage 10 Gsc and Otx2 ChIP-seq, and their respective input DNA datasets were obtained from the DDBJ Sequence Read Archive using the accession numbers DRA000508, DRA000510, DRA000576 and DRA000577 ([@R102]). **ChIP signal heatmaps:** The ChIP signal of histone modifications, Ep300, and TFs near Vegt, Otx1 and Foxh1 peaks were generated as follows. Using the TF summit file generated by MACS2 after peak calling, 2500 bp was added to the 5′ and 3′ sides of the summit to generate a 5000 bp peak window using Python v2.6.6. Heatmaps of ChIP signal were then generated against these locations where first, the ChIP datasets were processed as in the 'Genome browser visualization' section all the way through the IGVtools *sort* function (see above). After sorting, the BED files from this analysis were overlaid into the TF ChIP 5000 bp peak window using the Bedtools v2.19.1 ([@R79]) function *coverageBed*. The *coverageBed* output is pre-processed to generate ChIP signal in matrix form, and the signal matrix is plotted in R v3.1.0 using the *heatmap* function ([@R80]). **Comparison of ChIP read density:** The ChIP datasets were processed as in the 'Genome browser visualization' section all the way through the IGVtools *sort* function (see above). The total number of ChIP reads under peaks was quantified using the Bedtools v2.19.1 ([@R79]) function *coverageBed* and was then normalized to the length of each peak. This was defined as the ChIP read density. The ChIP read density between two populations of peaks were compared using the Wilcoxon rank sum test. **Super enhancer identification:** The sequences from the H3K4me1 ChIP-seq biological duplicates were concatenated into one file, which was then used for the super enhancer analysis. The H3K4me1 reads were aligned to the *X. tropicalis* genome v9.0 ([@R34]; [@R46]) using Bowtie 2 v2.2.7 ([@R52]) with default options, and then peak called against the stage 10 input DNA ([@R14]) using MACS2 v2.0.10 ([@R107]) with the cutoff of p value \< 10^−9^. The peaks that correspond to promoters were then excluded for further analysis. These regions were defined as peaks that overlap with 500 bp upstream or downstream of the transcription start site. Super enhancers were then identified using previously published methods ([@R60]; [@R98]) where first, the peaks were stitched while allowing for 12.5 kilobases of distance in-between. The H3K4me1 ChIP signal within the constituent enhancers inside these stitched regions were quantified as the total number of reads per million. These regions are then ranked, and the point where the slope of the H3K4me1 ChIP signal curve hits 45° was the point that distinguished 'regular enhancers' from 'super enhancers' using the Ranking of Super Enhancers (ROSE) algorithm. **Gene ontology:** Gene ontology was performed using The Gene Ontology consortium online tool assaying for enrichment for biological processes or molecular function ([@R5]; [@R92])

### Maternal gene expression of non-*Xenopus* otx genes {#S30}

Most early expression and functional information of *otx* genes were readily available from the following references: Wasp/*Nasonia vitripennis* ([@R62]); Flour beetle/*Tribolium castaneum* ([@R87]); Fruit fly/*Drosophila melanogaster* ([@R55]); Sponge/*Amphimedon queenslandica* ([@R55]); Sea anemone/*Nematostella vectensis* ([@R35]); Star-fish/*Asterina miniata* ([@R36]); Sea urchin/*Strongylocentrotus purpuratus* ([@R66]; [@R74]); Acorn worm/*Ptychodera flava* ([@R29]); Sea pineapple/*Halocynthia roretzi* ([@R96]; [@R95]); Ciona/*Ciona savignyi* ([@R85]); Ciona/*Ciona intestinalis* ([@R63]); Amphioxus/*Branchiostoma belcheri* ([@R101]); Skate/*Leucoraja erinacea* ([@R90]); Bichir/*Polypterus senegalus* ([@R90]); Fugu/*Fugu niphobles* ([@R90]); Goby/*Leucopsarion petersii* ([@R45]); Zebrafish/*Danio rerio* ([@R67]; [@R1]); Axolotl/*Ambystoma mexicanum* ([@R41]); Chick/*Gallus gallus* ([@R40]); and Human/*Homo sapiens* ([@R99]). For those not readily available, the early embryonic RNA-seq datasets were obtained from NCBI GEO using the accession numbers GSE22830 for zebrafish ([@R1]) and GSE86592 for chick ([@R40]) and were aligned to their respective genomes ([@R39]; [@R97]) using RSEM v.1.2.12 ([@R56]) and Bowtie 2 v2.2.7 ([@R52]).

DATA AND SOFTWARE AVAILABILITY {#S31}
------------------------------

Raw and processed RNA-seq and ChIP-seq datasets generated for this study are available at NCBI Gene Expression Omnibus using the accession GEO: GSE118024.\`
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![Screen for Core Maternal Endodermal TFs\
(A) Dissection of six to eight 8-cell stage embryos in 3 biological replicates at 2 h post-fertilization (hpf) to separate animal and vegetal blastomeres for RNA sequencing.\
(B) Log2-transformed transcripts per million (TPM) expression of TFs in animal and vegetal blastomeres. Differentially expressed TFs are highlighted in green (vegetal) or orange (animal).\
(C) Log2-transformed fold change (animal over vegetal) of expression levels of localized TFs.\
(D--F) *In situ* hybridization showing *otx1* expression (cells in blue) in the vegetal mass cells (presumptive endoderm) during early blastula (D), late blastula (E), and early gastrula (F).](nihms-1531065-f0002){#F1}

![Vegt and Otx1 Are Dual Function TFs in the Endoderm\
(A) Ectopic expression of *otx1* in animal caps shows the induction of endodermal genes by RT-qPCR. *dicer1* was used for normalization. Shown is a single representative biological replicate out of 3. Error bars represent variation from 3 technical replicates.\
(B) Single and combined ectopic expression of 100 pg *otx1* mRNA and 100 pg *vegt* mRNA shows synergistic and antagonistic co-regulation by RT-qPCR. *dicer1* was used for normalization. Shown is a single representative biological replicate out of 3. Error bars represent variation from 3 technical replicates.\
(C) Combinatorial ectopic expression of *vegt* and *otx1* in the animal cap using dosage titration to assay for similarly co-regulated genes by RT-qPCR. Yellow diamond indicates the subthreshold concentration of *vegt*, with which titrating doses of *otx1* mRNA are co-injected. RNA doses are expressed in picograms. *dicer1* was used for normalization. Shown is a single representative biological replicate out of 3. Error bars represent the variation from 3 technical replicates.\
(D) Two biological replicates from (C) were subjected to RNA-seq. Genes that are similarly co-regulated as *nodal*, *mixer*, and *fgf20* were identified by correlating gene expression in TPM using the Pearson correlation coefficient. Plotted is the spatial expression pattern in the gastrula stage of genes that are positively co-regulated (*nodal* type and *mixer* type) or negatively co-regulated (*fgf20*-type) by *vegt* and *otx1*.\
(E and F) Vegt and Otx1 morpholinos were injected independently or together to vegetal masses at the 1-cell stage, and vegetal masses were assayed by RNA-seq at stage 10 in biological duplicates. The Venn diagrams show genes that are downregulated (E) or upregulated (F) in different conditions, where regulation is identified as a \>2-fold change in gene expression compared to uninjected control.\
(G and H) Fold change expression of downregulated (G) or upregulated (H) genes in the RNA-seq datasets in TPM over uninjected control, along with a set of 300 randomly sampled genes. Significance was determined using the Student's t test.\
(I) Expression of mesodermal (*fgf20*, *mespa*) genes and endodermal (*foxa1*, *hnf1b*) genes in the morpholino RNA-seq experiment in TPM.\
(J) Gastrula stage spatial expression of genes that are downregulated and upregulated in the double morpholino experiment, along with a set of 300 randomly sampled genes. TPM is in log2 scale.](nihms-1531065-f0003){#F2}

![Vegt and Otx1 Bind to the Chromatin near Mesendodermal Genes Pre-ZGA\
(A) Venn diagram of Otx1 and Vegt biologically reproducible peak overlaps.\
(B) Genome browser view of Otx1 and Vegt ChIP-seq near endodermal (*nodal6*, *sox17b.1*, *sox17b.2*, *mixer*, *mix1*), mesodermal (*fgf20*), and mesendodermal (*gsc*, *hhex*) genes.\
(C) Genomic annotation of the location of all Vegt, all Otx1, and Vegt+Otx1 overlapping peaks.\
(D) Gastrula stage expression pattern of genes associated with all Vegt, all Otx1, and Vegt+Otx1 overlapping peaks. Genes were assigned as "endoderm," "mesoderm," or "ectoderm," based on which germ layer showed the highest expression in TPM.\
(E and F) Chromatin binding of Vegt (E) and Otx1 (F) near genes involved in germ layer formation identified using ChIP-qPCR on 32-cell stage embryos. *eef1a1* and *ins* promoters were used as negative control. The error bars represent the variation from 3 technical replicates.](nihms-1531065-f0004){#F3}

![Otx1, Vegt, and Foxh1 Form an Assembly in the Chromatin\
(A) Venn diagram of Otx1, Vegt, and Foxh1 biologically reproducible peak overlaps.\
(B) Genome browser view of Otx1, Vegt, and Foxh1 binding, highlighting 4 regions of peak overlaps near the *bpm7.2*, *pou5f3.3*, *fgf20*, and *nodal6* genes.\
(C) Sequential ChIP-qPCR using anti-Otx1 followed by anti-FLAG, anti-Vegt, or anti-Foxh1 antibody in regions of peak overlap highlighted in (B). *ins* and *id3* promoters were used as negative controls. The error bars represent variation from 3 technical replicates.\
(D) Foxh1 morpholino KD followed by Otx1 or Vegt ChIP-qPCR performed on stage 8 embryos. *eef1a1* and *odc1* promoters were used as negative control. Shown is a single representative biological replicate. The error bars represent the variation from 3 technical replicates.](nihms-1531065-f0005){#F4}

![Combinatorial Otx1, Vegt, and Foxh1 Binding Pre-marks Zygotic *cis*-Regulatory Modules\
(A) Genome browser of maternal Otx1, Vegt, and Foxh1 binding with Pol II binding, mesendodermal zygotic TF binding (b-catenin, Foxa, Gsc, Otx2, and Smad2/3), and enhancer marks (Ep300, H3K27ac, and H3K4me1) near the genes *foxa4*, *pnhd*, and *admp*.\
(B) Zygotically active TF ChIP-seq signal of b-catenin, Foxa, Gsc, Otx2, and Smad2/3 in OVF-CRMs and 1- to 2-TF CRMs during the gastrula stage.\
(C) Heatmap of H3K4me3 promoter mark ChIP-seq signal in OVF-CRMs, 1--2 TF CRMs, and gene promoters as a positive control.\
(D--F) Heatmap of enhancer marks H3K4me1 (D), Ep300 (E), and H3K27ac (F) ChIP-seq signal in OVF-CRMs and 1-to 2-TF CRMs.\
(G) Fold change of Pol II ChIP-qPCR signal at gastrula stage 10.5 from animal caps ectopically expressing *otx1* and *vegt* mRNA assaying for association with OVF-CRMs, compared to uninjected animal caps. Shown is a single representative biological replicate. The error bars represent the variation from 3 technical replicates.\
(H) Fold change of Pol II ChIP-qPCR signal at stage 10.5 from vegetal masses in Otx1, Vegt, and Foxh1 triple morpholino KD conditions assaying for association with OVF-CRMs, compared to uninjected vegetal masses. Shown is a single representative biological replicate. The error bars represent the variation from 3 technical replicates.\
(I) RT-qPCR assay for eRNA transcription from OVF-CRMs in uninjected, and *otx1* and *vegt* mRNA injected animal caps at stage 10.5. Genomic DNA contamination is quantified using an RT-qPCR control reaction with no reverse transcriptase (--RT). Shown is a single representative biological replicate. The error bars represent the variation from 3 technical replicates.\
The experiments for (G)--(I) were repeated at least twice.](nihms-1531065-f0006){#F5}

![Otx1, Vegt, and Foxh1 Establish SEs near Key Endodermal Genes\
(A) Categorization of H3K4me1 enhancer regions as regular enhancers (REs) and super-enhancers (SEs) using the rank order of super-enhancers (ROSE) algorithm based on H3K4me1 signal.\
(B) Length of RE and SE in kilobases.\
(C) Number of constituent enhancers (H3K4me1 peaks) within REs and SEs.\
(D) Genome browser view of SEs in the *pnhd*, *admp*, *foxa4*, and *sox17* locus, which are populated with Otx1, Vegt, and Foxh1 ChIP-seq peaks.\
(E) Comparison of epigenetic marks in REs and SEs focusing on heterochromatin, enhancer, and polycomb marks. Plotted is the fold change of the median ChIP read density in SE over RE.\
(F) Maternal TF ChIP read density in REs and SEs.\
(G) Overlap of 1-TF, 2-TF, or 3-TF CRMs (OVF-CRMs) peaks with the H3K4me1-identified REs or SEs.\
(H) GO analysis of genes associated with SEs.\
(I) Temporal expression of genes associated with REs and SEs, along with randomly selected genes, normalized to the gene expression at 0 hpf.\
(J) Gastrula stage spatial expression of genes associated with REs and SEs, along with randomly selected genes in log2(TPM).\
(K) Log2-fold change of gene expression in Vegt + Otx1 MO and Foxh1 MO over uninjected control of genes associated with REs and SEs, along with randomly selected genes.\
Significance for (E) and (F) was determined using the Wilcoxon rank-sum test by comparing the signals in the set of SEs (N = 441) to the set of REs (N = 7,468). The significance for (K) was determined using the Wilcoxon rank-sum test whereby the number of random genes was sampled to the number of SE genes (N = 490) from the set of genes not associated with REs or SEs. The number of RE genes was sampled down to the number of SE genes.](nihms-1531065-f0007){#F6}

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE                                                                                                                        SOURCE                          IDENTIFIER
  ------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------- -------------------------------------------------------------------------------
  Antibodies                                                                                                                                                                 
                                                                                                                                                                             
  Mouse monoclonal anti-Pol II 8WG16, ascites                                                                                                Bio-Legend                      MMS-126R
  Mouse monoclonal anti-Flag                                                                                                                 Sigma-Aldrich                   Cat\#F3165
  Rabbit polyclonal anti-Vegt                                                                                                                [@R91]                          N/A
  Rabbit polyclonal anti-Foxh1                                                                                                               [@R16]                          N/A
  Rabbit polyclonal anti-Otx1, designed against the peptide sequence GYTGTGLPFNSSDC (AA 288--101 of the *Xenopus tropicalis* Otx1 protein)   GenScript; This Paper           N/A
  Rabbit polyclonal anti-H3K4me1                                                                                                             Abcam                           Cat\#ab8895
                                                                                                                                                                             
  Chemicals, Peptides, and Recombinant Proteins                                                                                                                              
                                                                                                                                                                             
  Dynabeads Protein G                                                                                                                        Life Technologies               Cat\#10003D
                                                                                                                                                                             
  Critical Commercial Assays                                                                                                                                                 
                                                                                                                                                                             
  mMessage mMachine Sp6 Transcription Kit                                                                                                    Thermo Fisher Scientific        Cat\#AM1340
  SYBR Green I Master                                                                                                                        Roche                           Cat\#04707516001
  NEXTflex ChIP-seq kit                                                                                                                      Bioo Scientific                 Cat\#NOVA-5143--01
  Superscript II                                                                                                                             Life Technologies               Cat\#18064014
  KAPA HiFi HotStart ReadyMix (2x)                                                                                                           Kapa Biosystems                 Cat\#KK2601
  Agencourt AMPure XP beads                                                                                                                  Beckman Coulter                 Cat\#A63881
  Nextera DNA Library Prep Kit                                                                                                               Illumina                        Cat\#FC-121--1030
  TURBO DNase                                                                                                                                Thermo Fisher                   Cat\#AM2238
                                                                                                                                                                             
  Deposited Data                                                                                                                                                             
                                                                                                                                                                             
  *X. tropicalis* RNA-seq and ChIP-seq                                                                                                       This Paper                      GEO:GSE118024
  *X. tropicalis* genome version 9.0                                                                                                         [@R34]; [@R46]                  RRID:SCR_003280; URL: <http://www.xenbase.org/entry/>
  *X. tropicalis* gastrula stage (Stage 10.5) dissected fragments, RNA-seq                                                                   [@R8]                           GEO:GSE81458
  *X. tropicalis* wild type embryo temporal profiling, RNA-seq                                                                               [@R71]                          GEO:GSE65785
  *X. tropicalis* Stage 8 ChIP-seq input DNA                                                                                                 [@R14]                          GEO:GSE85273
  *X. tropicalis* Foxh1 Stage 8, ChIP-seq                                                                                                    [@R14]                          GEO:GSE85273
  *X. tropicalis* Pol II Stage 7--10, ChIP-seq                                                                                               [@R14]                          GEO:GSE85273
  *X. tropicalis* Foxa Stage 10, ChIP-seq                                                                                                    [@R14]                          GEO:GSE85273
  *X. tropicalis* H3K9me2 Stage 9--30, ChIP-seq                                                                                              [@R37]                          GEO:GSE67974
  *X. tropicalis* H4K20me3 Stage 9--30, ChIP-seq                                                                                             [@R37]                          GEO:GSE67974
  *X. tropicalis* H3K4me1 Stage 9--30, ChIP-seq                                                                                              [@R37]                          GEO:GSE67974
  *X. tropicalis* Ep300 Stage 8--30, ChIP-seq                                                                                                [@R37]                          GEO:GSE67974
  *X. tropicalis* H3K4me3 Stage 8--30, ChIP-seq                                                                                              [@R37]                          GEO:GSE67974
  *X. tropicalis* H3K4me1 Stage 8--10, ChIP-seq                                                                                              [@R28]                          GEO:GSE56000
  *X. tropicalis* H3K27ac Stage 8--10, ChIP-seq                                                                                              [@R28]                          GEO:GSE56000
  *X. tropicalis* Ctnnb1 Stage 10, ChIP-seq                                                                                                  [@R68]                          GEO:GSE72657
  *X. tropicalis* Smad2/3 Stage 10, ChIP-seq                                                                                                 [@R16]                          GEO:GSE53654
  *X. tropicalis* Gsc Stage 10, ChIP-seq                                                                                                     [@R102]                         DRA:DRA000576; DRA000577
  *X. tropicalis* Otx2 Stage 10, ChIP-seq                                                                                                    [@R102]                         DRA:DRA000508; DRA000510
  *X. tropicalis* Jarid Stage 9, ChIP-seq                                                                                                    [@R93]                          GEO:GSE41161
  *X. tropicalis* Ezh2 Stage 9, ChIP-seq                                                                                                     [@R93]                          GEO:GSE41161
  *X. tropicalis* Foxh1 MO, RNA-seq                                                                                                          [@R16]                          GEO:GSE53654
                                                                                                                                                                             
  Experimental Models: Organisms/Strains                                                                                                                                     
                                                                                                                                                                             
  *X. tropicalis*, out-bred Nigerian                                                                                                         University of Virginia, NASCO   URL: <https://www.enasco.com/>
                                                                                                                                                                             
  Oligonucleotides                                                                                                                                                           
                                                                                                                                                                             
  Template switching oligo                                                                                                                   [@R75]                          N/A
  ISPCR primers                                                                                                                              [@R75]                          N/A
  Indexing primers                                                                                                                           [@R10]                          N/A
  Primers for RT-qPCR and ChIP-qPCR (See [Table S5](#SD5){ref-type="supplementary-material"})                                                Integrated DNA Technologies     N/A
  Otx1 MO 5′- ATGACATCATGCTCAAGGCTGGACA-3′                                                                                                   GeneTools; This Paper           N/A
  Vegt MO 5′-TGTGTTCCTGACAGCAGTTTCTCAT-3′                                                                                                    GeneTools; [@R81]               N/A
  Foxh1 MO 5′-TCATCCTGAGGCTCCGCCCTCTCTA-3′                                                                                                   GeneTools; [@R16]               N/A
                                                                                                                                                                             
  Recombinant DNA                                                                                                                                                            
                                                                                                                                                                             
  pCS2+otx1 (*X. tropicalis otx1* ORF)                                                                                                       This paper                      N/A
  pCS2+vegt (*X. tropicalis vegt* ORF)                                                                                                       This paper                      N/A
  pCS2+3xFLAG-otx1 (*X. tropicalis otx1* ORF)                                                                                                This paper                      N/A
                                                                                                                                                                             
  Software and Algorithms                                                                                                                                                    
                                                                                                                                                                             
  RSEM v.1.2.12                                                                                                                              [@R56]                          RRID:SCR_013027; URL: <http://deweylab.biostat.wisc.edu/rsem/>
  Bowtie 2 v2.2.7                                                                                                                            [@R52]                          RRID:SCR_016368; URL: <http://bowtie-bio.sourceforge.net/bowtie2/index.shtml>
  EBseq v1.8.0                                                                                                                               [@R54]                          RRID:SCR_003526;URL: <https://www.biostat.wisc.edu/~kendzior/EBSEQ/>
  R v3.1.0                                                                                                                                   [@R80]                          RRID:SCR_001905; URL:<http://www.r-project.org/>
  MACS2 v2.0.10                                                                                                                              [@R107]                         RRID:SCR_013291;URL: <https://github.com/taoliu/MACS>
  Irreproducibility Discovery Rate                                                                                                           [@R58]                          URL: <https://sites.google.com/site/anshulkundaje/projects/idr>
  HOMER v4.7                                                                                                                                 [@R33]                          RRID:SCR_010881;URL: <http://homer.ucsd.edu/homer/>
  DREME                                                                                                                                      [@R6]                           RRID:SCR_001783; URL: <http://meme-suite.org/>
  TOMTOM                                                                                                                                     [@R27]                          RRID:SCR_001783; URL: <http://meme-suite.org/>
  Samtools v0.1.19                                                                                                                           [@R57]                          RRID:SCR_002105; URL: <http://samtools.sourceforge.net/>
  Bedtools v2.19.1                                                                                                                           [@R79]                          RRID:SCR_006646; URL: <https://github.com/arq5x/bedtools2>
  IGV v2.3.20                                                                                                                                [@R83]                          RRID:SCR_011793; URL: <http://software.broadinstitute.org/software/igv/>
  Sratoolkit v2.8.1                                                                                                                          NCBI NIH                        URL: <https://www.ncbi.nlm.nih.gov/sra/docs/toolkitsoft/>
  Gene Ontology                                                                                                                              [@R5]; [@R92]                   RRID:SCR_002143;URL: <http://geneontology.org/>
  Rank Ordering of Super-Enhancers (ROSE)                                                                                                    [@R60]; [@R98]                  URL: <http://younglab.wi.mit.edu/super_enhancer_code.html>

###### Highlights

-   Otx1 and Vegt drive endoderm fate as dual-function transcription factors (TFs)

-   Otx1, Vegt, and Foxh1 co-occupy enhancers and control zygotic gene activation (ZGA)

-   TF co-occupancy precedes chromatin dynamics in enhancers and super-enhancers

-   Super-enhancer-associated genes are endodermal factors activated during ZGA
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